Related Experiment Video
Updated: May 10, 2026
06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Nanoparticles in the ocular drug delivery
Hong-Yan Zhou1, Ji-Long Hao, Shuang Wang
1Department of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China.
International Journal of Ophthalmology
|July 5, 2013
Summary
Nanoparticles (NPs) offer a promising solution for ocular drug delivery, overcoming biological barriers to enhance drug penetration and efficacy for various eye diseases. DNA NPs show potential for gene therapy applications.
Area of Science:
- Ophthalmology
- Nanotechnology
- Drug Delivery
Background:
- Ocular drug delivery faces significant challenges due to biological barriers like the ocular surface epithelium and blood-retina barrier.
- Traditional methods are often inefficient, particularly for poorly soluble drugs and posterior segment diseases.
- Drug clearance via ocular vessels and lymphatics further limits therapeutic efficacy.
Purpose of the Study:
- To review recent advancements in nanoparticle (NP) drug delivery systems for treating ocular diseases.
- To highlight the potential of NPs in overcoming ocular barriers and improving drug penetration.
- To discuss the application of DNA NPs in ocular gene therapy.
Main Methods:
- Review of recent scientific literature on nanoparticle-based ocular drug delivery.
- Analysis of NP strategies designed to penetrate ocular barriers (cornea, retina, choroid).
- Evaluation of DNA nanoparticles for enhanced transfection efficiency in ocular gene therapy.
Main Results:
- Nanoparticles effectively overcome ocular barriers, increasing drug penetration to target sites.
- NPs enable sustained drug levels with lower doses and reduced toxicity compared to conventional eye drops.
- DNA NPs demonstrate high specificity and multifunctionality, improving transfection efficiency for gene therapy.
Conclusions:
- Nanoparticle-based systems represent a significant advancement in ocular drug delivery.
- NPs offer a versatile platform for treating diverse ocular conditions, including those requiring gene therapy.
- Targeted NP delivery to the cornea, retina, and choroid is achievable via surface applications and intravitreal injection.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...